K
Kei Omoda
Researcher at Hiroshima University
Publications - 11
Citations - 134
Kei Omoda is an academic researcher from Hiroshima University. The author has contributed to research in topics: Medicine & Prodrug. The author has an hindex of 6, co-authored 9 publications receiving 126 citations.
Papers
More filters
Journal ArticleDOI
Dosage adjustment of ribavirin based on renal function in Japanese patients with chronic hepatitis C.
Yorinobu Maeda,Yoshie Kiribayashi,Takashi Moriya,Akira Maruhashi,Kei Omoda,Sachiyo Funakoshi,Teruo Murakami,Mikihisa Takano +7 more
TL;DR: Results indicate that CLtotal of ribavirin is dependent on renal function (creatinine clearance), and hemolysis is induced by high Ribavirin concentrations in plasma.
Journal ArticleDOI
Correlation between plasma concentration ratios of SN-38 glucuronide and SN-38 and neutropenia induction in patients with colorectal cancer and wild-type UGT1A1 gene
Koichi Hirose,Chihiro Kozu,Koshiro Yamashita,Eiji Maruo,Mizuho Kitamura,Junichi Hasegawa,Kei Omoda,Teruo Murakami,Yorinobu Maeda +8 more
TL;DR: UGT activity involved in SN-38 metabolism is variable among patients with the wild-type UGT1A1 gene, and each CPT-11 treatment suppresses UGT activity, according to a modified high-performance liquid chromatography method.
Journal ArticleDOI
Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human
Kei Omoda,Teruo Murakami,Ryoko Yumoto,Junya Nagai,Yorinobu Maeda,Yoshie Kiribayashi,Mikihisa Takano +6 more
TL;DR: The pharmacokinetic interaction between VPA and carbapenem antibiotics, in which plasma VPA levels were markedly reduced, may partly be derived from the increased erythrocyte distribution of VPA.
Journal ArticleDOI
Effects of aluminium-containing antacid on bioavailability of ofloxacin following oral administration of pivaloyloxymethyl ester of ofloxacin as prodrug
Yorinobu Maeda,Kei Omoda,Toshio Konishi,Makoto Takahashi,Kenji Kihira,Satoshi Hibino,Satsuki Tsukiai +6 more
TL;DR: Observations indicate that this new compound is likely to offer a prodrug for avoidance of interaction between new quinolone and metal cations.
Journal ArticleDOI
Evaluation of clinical efficacy of Maeda's nomogram for vancomycin dosage adjustment in adult Japanese MRSA pneumonia patients.
TL;DR: The Maeda's nomogram regimen with a 1,000 mg vancomycin dose was shown to achieve target plasma levels of van comycin at a higher rate and provide higher clinical efficacy in vancomYcin therapy of MRSA pneumonia patients, as compared with the currently available standard dosage regimen.